Press release


Powered by ChronoForms -

Last week Timur Galimov, our Chief Technology Officer, and Olga Sokolova, System Analysis Director, conducted a 2-day training for our client Novo Nordisk, a global healthcare company with more than 90 years history of innovation and leadership in diabetes care.

Flex Databases team walked Novo Nordisk team through the system, demonstrated functionality peculiarities. The system will support clinical trials management. It was a great example of teamwork of both Pharma and IT company, an example of successful implementation. Training raised lots of interesting questions and there was a ton of positive feedback. We are proud to be a part of innovative studies!    

To get more info about our clinical trials solutions, please This email address is being protected from spambots. You need JavaScript enabled to view it. or request a demo. 


You may also be interested in
Flex Databases is always ready to support you in any challenging situation. And today, when GDPR came into effect, we are here to demonstrate that with us you are fully prepared to it in terms of our...
Clinical Trials are notoriously expensive to operate, with the majority of trial sites working with no more than a 3-month operating budget. That means that maintaining up-to-date financial records, a...
The past few years have created something of a boom in the development of Blockchain technology and its emerging applications within various industries and spheres of life. Following our strategic pol...
Flex Databases team - Olga Loginovskaya, MD Chief Quality and Corporate Officer and Natalia Blagodarova, QA Department Director, took part in Quality Assurance Forum in Moscow, Skolkovo Innovation For...


DIABIOIPhEBCTMSEDCLMSe-CRFFDACROquizFlex JournalpharmacovigilanceinfographicGCPSCOPE

Powered by ChronoForms -

Request Demo

Get in touch for a demo of our system. Fill in the form and we’ll contact you to demonstrate the system in action.

Powered by ChronoForms -

Ваша заявка отправлена

Спасибо за Ваш интерес! Вы подписаны на нашу новостную рассылку.

Your request send

Thank you for your interest! You are subscribed to our newsletter